Results 11 to 20 of about 409,848 (384)
Introduction Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by a low platelet count (
J. Bussel+4 more
semanticscholar +5 more sources
Risk factors for thrombocytopenia associated with intravenous valproic acid therapy in pediatric patients undergoing neurosurgical operations [PDF]
Thrombocytopenia is one of the side effects of VPA. This study aimed to evaluate the incidence and risk factors of thrombocytopenia after intravenous VPA treatment in children with neurosurgical operations.
Zhaosong Du+4 more
doaj +2 more sources
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
Background Several cases of unusual thrombotic events and thrombocytopenia have developed after vaccination with the recombinant adenoviral vector encoding the spike protein antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (ChAdOx1
A. Greinacher+5 more
semanticscholar +2 more sources
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors’ clinical recommendations.
T. Shamsi
semanticscholar +4 more sources
Thrombocytopenia in hypertensive disorder of pregnancy: maternal and perinatal outcome [PDF]
Background: Pregnancy induced hypertension (PIH) is one of the most common causes of both maternal and neonatal morbidity. A variety of haematological abnormalities may occur in women with PIH of which thrombocytopenia is the most common.
Varsha Deshmukh +2 more
doaj +1 more source
Understanding Immune Thrombocytopenia: Looking Out of the Box
The pathogenesis of immune thrombocytopenia (ITP) is increasingly being elucidated, and its etiology is becoming more frequently identified, leading to a diagnostic shift from primary to secondary ITP.
Alexandra Schifferli+8 more
doaj +1 more source
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
Summary We report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 10 days after receiving the first dose of the ChAdOx1 nCoV-19 adenoviral vector vaccine against coronavirus disease 2019 (Covid-19).
N. H. Schultz+10 more
semanticscholar +1 more source
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis
Background Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is a new syndrome associated with the ChAdOx1 nCoV-19 adenoviral vector vaccine against severe acute respiratory syndrome coronavirus 2. Data are lacking on the clinical features of
S. Pavord+8 more
semanticscholar +1 more source
SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
The coronavirus disease 2019 (Covid-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stimulated the development of highly effective vaccines that were produced wi...
D. Cines, J. Bussel
semanticscholar +1 more source
Frequency of Thrombocytopenia in Malaria and its prognostic significance
BACKGROUND & OBJECTIVE: Thrombocytopenia is a common hematological manifestation of malaria, but locally there is limited data on the association of thrombocytopenia degree and malarial species in Pakistan.
Saleh Ahmad+3 more
doaj +1 more source